title: [Access to intermittent preventive treatment (IPt) in a situation of abolition of user's fee: role of economic welfare].
abstract: In Senegal, the free distribution of sulfadoxine pyrimethamine during antenatal care is recommended to remove the disparity in the context of intermittent preventive treatment against malaria. The objective of this study was thus to identify factors influencing access to treatment in a situation of abolition of user fees. It was a cross-sectional and analytical study. It covered a sample of 1906 women aged 15-49 years randomly selected during the national survey on malaria in Senegal. Data were collected during a personal interview. The economic well-being was measured from the characteristics of housing and durable goods. The multivariate analysis was performed using logistic regression. The average age was 27.94 ± 5.34, 64.27% resided in rural area and 71.8% had received no schooling. Among the surveyed women, 23% were in the poorest quintile, while 16.3% were in the richest. Intermittent preventive treatment was performed in 49.3%. IPt were made more in urban areas (OR 1.45 95% [1.17 to 1.72]). It increased with the level of education with an OR of 1.5 and 1.68 in primary and secondary. The completion of the IPt increased with economic welfare. The OR ranged from 1.44 to 2.95 in the second quintile to the richest. Free medication does not necessarily benefit poor people. Other accompanying measures must be developed to facilitate the distribution of drugs particularly at community level with the involvement of people.
authors.affiliation: Institut de santé et développement, Université Cheikh-Anta-Diop, Dakar, Sénégal. adamafaye94@hotmail.com
authors.forename: A
authors.initials: A
authors.lastname: Faye
authors.forename: N M
authors.initials: NM
authors.lastname: Manga
authors.forename: I
authors.initials: I
authors.lastname: Seck
authors.forename: K
authors.initials: K
authors.lastname: Niang
authors.forename: M M
authors.initials: MM
authors.lastname: Leye
authors.forename: M
authors.initials: M
authors.lastname: Diagne-Camara
authors.forename: M
authors.initials: M
authors.lastname: Diongue
authors.forename: M
authors.initials: M
authors.lastname: Ba
authors.forename: P
authors.initials: P
authors.lastname: Ndiaye
authors.forename: A
authors.initials: A
authors.lastname: Tal-Dia
mesh_terms: D000293:Adolescent; D000328:Adult; D000962:Antimalarials / Q000627:therapeutic use; D004334:Drug Administration Schedule; D016527:Drug Costs / Q000706:statistics & numerical data; D005249:Fees and Charges; D005260:Female; D006297:Health Services Accessibility / Q000191:economics* / Q000706:statistics & numerical data; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000191:economics* / Q000517:prevention & control*; D008875:Middle Aged; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D011295:Prenatal Care / Q000191:economics / Q000379:methods; D012675:Senegal; D012946:Social Welfare / Q000191:economics*; D055815:Young Adult
chemical_list: D000962:Antimalarials